Palvella Therapeutics (PVLA) EBT (2013 - 2026)
Palvella Therapeutics' (PVLA) quarterly EBT came in at -$15.8 million in Q1 2026, down 92.63% year-on-year from -$214.0 million in Q1 2025, and down 23.39% on a QoQ basis from -$12.8 million in Q4 2025.
Palvella Therapeutics (PVLA) EBT (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of EBT data on file, last reported at -$15.8 million in Q1 2026.
- On a quarterly basis, EBT fell 92.63% year-over-year to -$15.8 million in Q1 2026; TTM through Mar 2026 was -$49.4 million, a 113.84% decrease from a year earlier, with the FY2025 full-year figure at -$41.8 million, down 139.64% from the prior year.
- EBT for Q1 2026 stood at -$15.8 million, down from -$12.8 million in the prior quarter.
- Over the last five years, EBT for PVLA reached as high as $15.0 million in Q4 2023 and fell as low as -$16.0 million in Q1 2023.
- Historically, EBT has averaged -$7.8 million across 5 years, with a median of -$9.5 million in 2025.
- Across the five-year window, EBT jumped 221.65% in 2023 and tumbled 366.92% in 2024, its largest moves.
- Year by year, EBT stood at -$12.3 million in 2022, then soared by 221.65% to $15.0 million in 2023, then plunged by 126.36% to -$4.0 million in 2024, then tumbled by 223.41% to -$12.8 million in 2025, then decreased by 23.39% to -$15.8 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$15.8 million in Q1 2026, -$12.8 million in Q4 2025, and -$11.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | -15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.77 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -11.35 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -3.95 Mn |
| Sep 30, 2024 | -6.78 Mn |
| Jun 30, 2024 | -4.17 Mn |
| Mar 31, 2024 | -2.54 Mn |
| Dec 31, 2023 | 14.99 Mn |
| Sep 30, 2023 | -12.31 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | -16.01 Mn |
| Dec 31, 2022 | -12.32 Mn |
| Sep 30, 2022 | -12.67 Mn |
| Jun 30, 2022 | -12.93 Mn |
| Mar 31, 2022 | -8.06 Mn |
| Dec 31, 2021 | -11.70 Mn |
| Sep 30, 2021 | -19.61 Mn |
| Jun 30, 2021 | -17.36 Mn |